Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: Incidence, clinical presentation and factors associated with severity during hospital stay

Infection

Volumn 38, Issue 6, 2010, Pages 453-458

  Ruiz, L A ^a   Gomez A ^a   Jaca, C ^a   Martinez L ^a   Gomez B ^a   Zalacain, R ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Bacteraemia; Community acquired pneumonia; Gram negative bacteria

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; BODY TEMPERATURE; BREATHING RATE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DEATH; DISEASE COURSE; DISEASE SEVERITY; DISORIENTATION; DYSPNEA; ENTEROBACTER SAKAZAKII; ESCHERICHIA COLI; FEVER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; HYPOXEMIA; INCIDENCE; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LEUKOCYTOSIS; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMONIA SEVERITY INDEX; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; RISK FACTOR; SEPTIC SHOCK; STENOTROPHOMONAS MALTOPHILIA; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INCIDENCE; MIDDLE AGED; PNEUMONIA; RISK FACTORS; TREATMENT OUTCOME;

EID: 78651291676     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0058-4     Document Type: Article

References (26)

1. D Koulenti J Rello 2006 Gram-negative bacterial pneumonia: aetiology and management Curr Opin Pulm Med 12 198 204 1:CAS:528:DC%2BD28XnvVChtbc%3D 16582675
2. ND Friedman KS Kaye JE Stout SA McGarry SL Trivete JP Briggs W Lamm C Clark J MacFarquhar AL Walton LB Reller DJ Sexton 2002 Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 791 799 12435215
3. M Falguera J Carratala A Ruiz-Gonzalez C García-Vidal I Gazquez J Dorca F Gudiol JM Porcel 2009 Risk factors and outcome of community acquired pneumonia due to gram negative bacilli Respirology 14 105 111 10.1111/j.1440-1843.2008.01371.x 18699803
4. F Arancibia T Bauer S Ewig J Mensa J Gonzalez MS Niederman A Torres 2002 Community acquired pneumonia due to gram negative bacteria and Pseudomonas aeruginosa Arch Intern Med 162 1849 1858 10.1001/archinte.162.16.1849 12196083
5. CI Kang JH Song WS Oh KS Ko DR Chung KR Peck 2008 Clinical outcomes and risk factors of community acquired pneumonia caused by gram negative bacilli Eur J Clin Microbiol Infect Dis 27 657 661 10.1007/s10096-008-0485-7 18317821
6. JG Bartlett RF Breiman LA Mandell TM File The Infectious Disease Society of America 1998 Community-acquired pneumonia in adults: guidelines for management Clin Infect Dis 26 811 838 1:STN:280:DyaK1c3isFKntg%3D%3D 10.1086/513953 9564457
7. American Thoracic Society 2001 Guidelines for the management of adults with community acquired pneumonia Am J Respir Crit Care Med 163 1730 1754
8. ML Metersky A Ma DW Bratzier PM Houck 2004 Predicting bacteraemia in patients with community acquired pneumonia Am J Respir Crit Care Med 169 342 347 10.1164/rccm.200309-1248OC 14630621
9. Falguera M, Trujillano J, Caro S, Menéndez R, Carratalá J, Ruiz-González A, Vilà M, García M, Porcel JM, Torres A, NAC-CALIDAD (Proyecto Integrado de Investigación de la Sociedad Española de Patología del Aparato Respiratorio sobre Infecciones Respiratorias de Vías Bajas) Study Group. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009; 49:409-16.
10. TJ Marrie H Durant L Yates 1989 Community acquired pneumonia requiring hospitalization: 5 year prospective study Rev Infect Dis 2 586 599
11. Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, de Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez-Gascón F, Torres A, Zalacain R, Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Area de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR: Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad (Sociedad Española de Neumología y Cirugía Torácica). Arch Bronconeumol 2005; 41:272-89.
12. MJ Fine TE Auble DM Yealy BH Hanusa LA Weissfeld DE Singer CM Coley TJ Marrie WN Kapoon 1997 A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 243 250 1:STN:280: DyaK2s7js1Gguw%3D%3D 10.1056/NEJM199701233360402 8995086 (Pubitemid 27044625)
13. J Dorca S Bello J Blanquer R de Celis L Molinos A Torres A Verano R Zalacain 1997 Diagnóstico y tratamiento de la neumonía adquirida en la comunidad Arch Bronconeumol 33 240 246 1:STN:280:DyaK2szisFWktQ%3D%3D 9254171 (Pubitemid 127528678)
14. PP España A Capelastegui I Gorordo C Esteban M Oribe M Ortega A Bilbao JM Quintana 2006 Development and validation of a clinical prediction rule for severe community acquired pneumonia Am J Respir Crit Care Med 174 1249 1256 10.1164/rccm.200602-177OC 16973986 (Pubitemid 44924826)
15. Levy MM, Fink M, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6. (Pubitemid 36444440)
16. WC Ko D Paterson A Sagnimeni D Hansen A Von Gotteborg S Mohapatra JM Casellas H Goossens L Mulazimoglu G Trenholme KP Klugman JG McCormack VL Yu 2002 Community acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns Emerg Infect Dis 8 160 166 10.3201/eid0802.010025 11897067
17. WS Leung CM Chu KY Tsang FH Lo KF Lo PL Ho 2006 Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome Chest 129 102 109 10.1378/chest.129.1.102 16424419 (Pubitemid 43265249)
18. JI García Paez FM Tengan AA Barone AS Levin SF Costa 2008 Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia Eur J Clin Microbiol Infect Dis 27 901 906 10.1007/s10096-008-0518-2
19. MB Allen K Prowse 1988 Bacteraemic Haemophilus influenzae pneumonia Eur Respir J 1 929 931 1:STN:280:DyaL1M7jslCnsg%3D%3D 3265667
20. KL Buising KA Thursky JF Black L MacGregor AC Street MP Kennedy GV Brown 2006 A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia Thorax 6 419 424 10.1136/thx.2005.051326 (Pubitemid 43723326)
21. R Menéndez A Torres R Zalacain J Aspa JJ Martín- Villasclaras L Borderías JM Benítez Moya J Ruiz-Manzano J Blanquer D Pérez C Puzo F Sánchez-Gascón J Gallardo CJ Alvarez L Molinos Neumofail Group 2004 Risk factors to treatment failure in community acquired pneumonia: implications for disease outcome Thorax 59 960 965 10.1136/thx.2003.017756 15516472 (Pubitemid 39490781)
22. Charles P, Wolf R, Whitby M, Fine MJ, Fuller AJ, Stirling R, Wright AA, Ramirez JA, Christiansen KJ, Waterer GW, Pierce RJ, Armstrong JG, Korman TM, Holmes P, Obrosky DS, Peyrani P, Johnson B, Hooy M, Australian Community-Acquired Pneumonia Study Collaboration, Grayson ML. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 2008; 47:375-84.
23. CL Kang SH Kim WB Park KD Lee HB Kim EC Kim MD Oh KW Choe 2005 Bloodstream infections caused by antibiotic-resistant gram negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome Antimicrob Agents Chemother 49 760 766 1:CAS:528: DC%2BD2MXht12ntbk%3D 10.1128/AAC.49.2.760-766.2005 15673761 (Pubitemid 40175690)
24. Y Siegman-Igra R Ravona H Primerman M Giladi 1998 Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes with particular emphasis on the effect of antibiotic therapy Int J Infect Dis 2 211 215 1:STN:280:DyaK1cvjslCktA%3D%3D 10.1016/S1201-9712(98)90055-8 9763504 (Pubitemid 28422099)
25. RB Osih JC McGregor SE Rich AC Moore JP Furuno EN Perencevich AD Harris 2007 Impact of empirical antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia Antimicrob Agents Chemother 51 839 844 1:CAS:528:DC%2BD2sXis1yqu7k%3D 10.1128/AAC.00901-06 17194829 (Pubitemid 46355264)
26. R Menéndez A Torres R Zalacain J Aspa J Martín L Borderías JM Benítez-Moya J Ruiz-Manzano FR de Castro J Blanquer D Pérez C Puzo F Sánchez-Gascón J Gallardo C Alvarez L Molinos NEUMOFAIL Group 2005 Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome Am J Respir Crit Care Med 172 757 762 10.1164/rccm.200411-1444OC 15937289 (Pubitemid 41324232)